Iscat

programme

Per day / Par jour

Type of sessions / Type de sessions

Partners / Partenaires

Per day / Par jour

Wednesday / Mercredi

Thursday / Jeudi

Friday / Vendredi

Per Day / Par Date

Wednesday / Mercredi

16

13.45 - 14.00

Cérémonie d'ouverture

ALIOT Etienne, Nancy - France

DE CHIILLOU Christian , Nancy - France

JAIS Pierre, Bordeaux - France

14.00 - 15.00

SALLE DEF
Session 1 |Les explorations électrophysiologiques endocavitaires

FAUCHIER Laurent , Tours - France
METTE Carole, Saint-Denis - France

Notions d’anatomie/physiologie pour comprendre la rythmologie

ECHIVARD Mathieu, Nancy - France

Quand et pourquoi demander une exploration ? (indications, réalisation pratique)

DAVRIL Clement, Nancy - France

Interprétation des signaux endocavitaires (en se basant sur des exemples concrets)

BEHAGHEL Albin, Angers - France

L’IDE en salle pendant une exploration

JUND Beatrice, Strasbourg - France

L’IDE en salle pendant une exploration

Benedicte MURER, Strasbourg - France

Table ronde

14.00 - 15.00

SALLE AB
Session 1 | 2024 AF ablation guidelines: what is new? And what remains to be determined

COMBES Stephane, Toulouse - France
DEFAYE Pascal, Grenoble - France

Risk factors and preprocedural management

PIOT Olivier, Saint-Denis - France

Indications and strategies in AF ablation

HOCINI Meleze, Bordeaux - France

Technical consideration

BOVEDA Serge, Toulouse - France

Post-procedural management

SELLAL Jean-Marc, Nancy - France

Discussion

15.00 - 16.00

SALLE DEF
Session 2 | Les ablations de tachycardies supraventriculaires

DA COSTA Antoine, Saint-Etienne - France
QUINQUIS Elisa, Brest - France

TRIN

HAGER François Xavier , Avignon - France

Voie accessoire

NINNI Sandro, Lille - France

Flutter atrial

JESEL MOREL Laurence, Strasbourg - France

QUIZ

BENALI Karim, Saint-Etienne - France

Table ronde

15.00 - 16.30

SALLE AB
Session 2 | AF and brain

FRONTERA Antonio, Milan - Italy
JAIS Pierre, Bordeaux - France

Cerebral conditions/modifications associated with AF

SIBON Igor, Bordeaux - France

Could we do better than CHADSVASC2 ? RHU TALENT

DUCHATEAU Josselin, Bordeaux - France

Silent brain infarcts and cognitive decline, the Swiss AF study

KRISAI Philipp, Basel - Switzerland

Silent cerebral events during ablation, role of energy and strategies for risk reduction

De POTTER Tom, Leuven - Belgium

Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation

KATO Takeshi, Kanazawa - Japan

Is AF ablation likely to help reducing AF associated cognitive decline?

RIVARD Lena, Montreal - Canada

Discussion

16.30 - 17.00

STUDIO B
Interpretation of on-board electrograms

Part 1: pacemakers

BOVEDA Serge, Toulouse - France

Part 1: pacemakers

DEFAYE Pascal, Grenoble - France

16.30 - 18.00

SALLE DEF
Session 3 | Troubles du rythme ventriculaire

SORIO Delphine, Rennes - France
WAINTRAUB Xavier, Paris - France

ESV quand proposer une ablation et comment la pratiquer ?

MANENTI Vladimir, Massy - France

Ablation de TV sur cardiopathie ischémique (indication, différentes stratégies substrat vs circuit)

FATEMI Marjaneh, Brest - France

Ablation de TV sur cardiopathie non-ischémique ou coeur sain

LESAFFRE François, Reims - France

Ablation de TV par voie épicardique (indication, complication)

PETIT Karine, Tours - France

L’IDE en salle pendant l’ablation de TV

FRANCO Sarah et MUNARETTO Cyrielle, Toulouse - France

Table ronde

17.00 - 18.15

SALLE AB
Session 3 | AF ablation

KNECHT Sebastien, Bruges - Belgium
REKVAVA Roin, Tbilisi - Georgia

Can AI based algorithms help selecting patients for long standing AF ablation?

WILLIAMS Steven, London - United-Kingdom

AF ablation should be offered to asymptomatic patients: - Pro

WILLEMS Stephan, Hamburg - Germany

AF ablation should be offered to asymptomatic patients: -Con

EXTRAMIANA Fabrice, Paris - France

Same day discharge (AF ablation program) - Pro

VOGLER Julia, Hamburg - Germany

Same day discharge (AF ablation program) - Con

FRONTERA Antonio, Milan - Italy

Discussion

Per Day / Par Date

Thursday / Jeudi

17

08.00 - 09.30

SALLE AB
Session 4 | Persistent AF Ablation

ALBENQUE Jean Paul, Toulouse - France
ANTER Elad, Tel Aviv - Israel
MARTIN Claire, Cambridge - UK

Are current mapping electrodes good enough?

SPECTOR Peter, Vermont - USA

Is there a Functional Substrate for AF

FRONTERA Antonio , Milan - Italy

Targeting scar/low voltage for persistent AF

ARENTZ Thomas, Freiburg - Germany

Electrogram based approach for persistent AF

SEITZ Julien, Marseille - France

Anatomical approach for persistent AF

DERVAL Nicolas, Bordeaux - France

Hybrid approach for AF Ablation

PORTA-SANCHEZ Andreu, Barcelona - Spain

Round Table

09.00 - 10.30

SALLE DEF
Session 4 | Se repérer / se guider : travail en collaboration IDE / ingénieur d’application

FINOT Emilie, Massy - France
PASQUIE Jean-Luc, Montpellier - France

En scopie / en ETO / en écho intra cardiaque

AMRAOUI Sana, Paris - France

Impact des rayonnements ionisants sur le personnel de santé

SELLAL Jean Marc, Nancy - France

Système CARTO

MENZRI Murielle et TISSIER Maxime, Nancy - France

Système ENSITE X

KHAMMAR Fatima - MONTOYA Thibaut et PIDOUX Isabelle, Bordeaux - France

Système RHYTHMIA

GUIBERT Jimmy et MOREAU Thomas, Le Mans et Voisins le Bretonneux - France

Table Ronde

09.30 - 10.30

SALLE AB
Session 5 | Everything you need to know about PFA

COMBES Stéphane, Toulouse - France
SCHERR Daniel, Graz - Austria

Understanding the different PFA solution

KORUTH Jacob, New York - USA

General anesthesia vs sedation?

GUNAWERDENE Melanie, Hamburg - Germany

Demonstrated benefits and real life studies

ANSELME Frederic, Rouen - France

Known and less obvious complications

MAURY Philippe, Toulouse - France

Round Table

10.30 - 11.00

STUDIO B
Interpretation of surface ECG traces, fine QRS

COMBES Nicolas, Toulouse - France

VENIER Sandrine, Grenoble - France

11.00 - 12.15

SALLE AB
Session 6 | Linear lesions for AF/AT

DERVAL Nicolas, Bordeaux - France
O'NEILL Mark, London - UK

AT post AF ablation: characteristics, mapping and prognosis

SCHERR Daniel, Graz - Austria

Is an epicardial approach needed and reasonable for linear ablation

JULIA CALVO Justo , Brighton - UK

Non macro reentrant AT: how to handle?

JAIS Pierre, Bordeaux - France

Roof-dependent flutter: where to perform the line ? will PFA simplify it?

PAMBRUN Thomas, Bordeaux - France

Debate: A mitral isthmus line is better than an anterior line : - I prefer a mitral isthmus line

KNECHT Sebastien, Bruges - Belgium

Debate: A mitral isthmus line is better than an anterior line : - I prefer anterior line

SARKOZY Andrea, Brussels - Belgium

Discussion

11.00 - 12.30

SALLE DEF
Session 5 | Les différentes énergies : travail en collaboration IDE / médecin

ALBA Céline , Nancy - France
CHEVALIER Philippe, Lyon - France

Radiofréquence

LATCU Gabriel et BRUN Caroline, Monaco - France

Cryoablation

SOCIE Pierre et PIGRENIER Daphné, Chartre - France

Electroporation

REYNAUD Nicolas et DENYS Caroline, Reims - France

Table Ronde

12.30 - 13.30

STUDIO B
EP study: interpretation of endocavitary tracings

CARRABELLI Adrien , Grenoble - France

GUY MOYAT Benoit , Limoges - France

13.15 - 14.20

SALLE AB
Session 7 | Sustainability in cardiac electrophysiology

CHAMP RIGOT Laure, Caen - France
MEYER Christian, Dusseldorf - Germany

What are the potential risks/limits associated with reuse and how to avoid them?

LE POLAIN de WAROUX Jean-Benoit, Bruges - Belgium

Value of remote vs in-house support for EP procedure

TILZ Roland, Luebeck - Germany

Industrial perspective

IHARA Zenichi, Abbott - BROOK Clare, Boston Scientific – BASU Shubhayu, Biosense Webster – POWELL David, Medtronic – VAHLE Viola, Vanguard,

Round Table

13.30 - 14.30

SALLE DEF
Session 6 | Pédiatrie, cardiopathie congénitale et canalopathie

MALTRET Alice, Paris - France
ZITOUNI TERKI Meriem, Le Plessis-Robinson - France

Troubles du rythme chez l’enfant : quelques pathologies responsables d’arythmies (T4F, fermeture de CIA…)

SACRISTAN Benjamin , Bordeaux - France

Prise en charge spécifique de l’enfant : quand ablater, quelques exemples d’arythmies.

GIRAULT Mélanie et MORENO Olivia , Paris - France

Syndrome de BRUGADA : test à l’ajmaline et ablation : chez qui ? quand ? comment ?

GOURRAUD Jean-Baptiste, Nantes - France

QUIZ

GUENANCIA Charles , Dijon - France

Table ronde

14.20 - 15.20

SALLE AB
Session 8 | Treatment of cardiac arrhythmias in specific conditions

JADCZYK Tomasz, Kravow - Poland
JESEL MOREL Laurence, Strasbourg - France

Anti-arythmic effect of HF drugs

WIEDMANN Felix, Heidelberg - Germany

AF ablation in HF with reduced/preserved EF

O'NEILL Louisa, Dublin - Ireland

AF ablation in inherited conditions

GANDJBAKHCH Estelle , Paris - France

Catheter ablation vs drugs in HF patients

BENALI Karim, Saint-Etienne - France

Round Table

14.30 - 15.30

SALLE DEF
Session 7 | Ambulatoire

ARTIGUES Laurence, Pau - France
CLEMENTY Nicolas, Montpellier - France
KLUG Didier, Lille - France

Pour quels types de procédure ? Exploration, ablation, tests médicamenteux

EL BOUAZZAOUI Rim , Libourne - France

Organisation d’un centre

GUELTON Marion et ROGE PICARD Franck , Rouen - France

Ablation de FA en ambulatoire ?

MONTASSIR Safa , Paris - Fance

Table ronde

15.30 - 16.00

STUDIO B
Interpretation of 3D maps

COMBES Stéphane, Toulouse - France

GUY MOYAT Benoit , Limoges - France

15.50 - 16.50

SALLE AB
Session 9 | Sudden cardiac death prediction

ALIOT Etienne, Nancy - France
MABO Philippe, Rennes - France
TILZ Roland, Lubeck - Germany

How SCD registries may help for SCD prevention

GARCIA Rodrigue, Poitiers - France

Can AI predict SCD?

DUBOIS Rémi, Bordeaux - France

Insight from PROFID registries

DAGRES Nikolaos, Berlin - Germany

Prediction of SCD underlying substrate by VF characteristics on ICD

HAISSAGUERRE Michel , Bordeaux - France

Round Table

16.00 - 17.00

SALLE DEF
Session 8 | La FA

FOURNIER Nathalie, Lyon - France
KUBALA Mathieu, Amiens - France

Les différents types de FA (définitions, mécanisme, impact…)

LAURENT Gabriel , Dijon - France

Ablation : quelle stratégie pour la parox / la persistante ?

BUN Sok-Sithikun, Nice - France

Pourquoi avons-nous toujours plus de patients à ablater ?

LEPILLIER Antoine, Paris - France

L’IDE en salle pendant l’ablation sous anesthésie locale / générale

BOURRAT Cédric et SABATIER Céline , Caen - France

Table ronde

16.50 - 18.00

SALLE AB
Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system

DEHARO Jean Claude, Marseille - France
FRONTERA Antonio, Milan - Italy

Interaction of autonomic nervous system and heart

SIPIDO Karin, Leuven - Belgium

Percutaneous sympathetic blockade for electrical storm

CLEQUIN Etienne, Bordeaux - France

Influence of neuromodulation on ventricular arrhythmias

BUCKLEY Una, Dublin - Ireland

Cardio neuromodulation indication and target

AKSU Tolga, Istanbul - Turkey

Cardioneuromodulation for functional AV block

REKVAVA Roin, Tbilisi - Georgie

Live in a box

DUCHATEAU Josselin , Bordeaux - France

Discussion

18.00 - 19.00

SALLE AB
Session 11 | Arrhythmia in Congenital Heart Disease

DERVAL Nicolas, Bordeaux - France
MALTRET Alice, Le Plessis Robinson - France

Surgical input of main congenital cardiac surgery and potential implication for arrhythmia

COMBES Nicolas, Toulouse - France

How imaging can improve the ablation procedure?

SACHER Frederic, Bordeaux - France

Ablation in TOF patients, can we avoid ICDs?

WALLET Justin, Leiden - Netherland

Live in a box

WALDMANN Victor, Paris - Fance

Round Table

Per Day / Par Date

Friday / Vendredi

18

08.15 - 09.30

SALLE AB
Session 12 | Unusual treatment for VT

DE CHIILLOU Christian, Nancy - France
KORUTH Jacob, New York - USA

Regeneration of the tissue is better than destroying it

ADELINO Raquel, Barcelona - Spain

VT from septal Substrate How to recognize and treat it?

MARCHLINSKI Francis, Philadelphia - USA

What can we expect from PFA in the ventricle

ANTER Elad, Tel Aviv - Israel

Live in a box / PFA for VT ablation

SACHER Frederic, Bordeaux - France

Live in a box - Ultra Low Cryo ablation

TILZ Roland, Lübeck - Germany

Round Table

09.00 - 10.30

SALLE DEF
Session 09 | Gestion des complications

METTE Carole, Saint-Denis - France
EXTRAMIANA Fabrice, Paris - France
TAIEB Jérôme, Aix-en-Provence - France

BAV complet

DEVROE Simon et VERDIN Anne Charlotte, Lomme - France

Tamponnade

GUIBERT Jimmy , Le Mans - France

Sus décalage

TIXIER Romain, Bordeaux - France

Hématome/fistule

LELLOUCHE Nicolas , Paris - France

ACR

MASSOULLIE Grégoire , Clermont-Ferrand - France

Quiz ECG

METTE Carole, Saint-Denis - France

Table ronde

09.30 - 10.30

SALLE AB
Session 13 | Assessing the substrate of ventricular arrhythmia

MARCHLINSKI Frank, Philadelphia - USA
PORTA SANCHEZ Andreu, Barcelona - Spain

Substrate Mapping for Ventricular Tachycardia: Assumptions and Misconceptions

ANTER Elad, Tel Aviv - Israel

Can imaging identify VT circuit?

JAIS Pierre, Bordeaux - France

MRI to predict VT occurrence

DE CHIILLOU Christian , Nancy - France

Imaging guidance or functional mapping of the ventricular substrate, how to integrate them in an easy way?

ROCA-LUQUE Ivo, Barcelona - Spain

Round Table

10.40 - 11.00

STUDIO B
Interpretation of 3D maps

VENIER Sandrine , Grenoble - France

VOGLIMACCI Quentin, Toulouse - France

11.00 - 12.00

SALLE AB
Session 14 | What is beyond bipolar depolarization mapping for ventricular arrhythmias

ANTER Elad, Tel Aviv - Israel
MARTINS Raphael, Rennes - France

How to assess ventricular repolarization in humans

CORONEL Ruben, Amsterdam - Netherland

How to best define VT substrate/ circuit using different tools? Unipolar/bipolar EGM, omnipolar/ near-field technology or repolarization

PORTA SANCHEZ Andreu, Barcelona - Spain

Ventricular substrate assessment, Should I do it during SR, RV pacing or ES?

MARTIN Claire, Cambridge - UK

Discussion

11.00 - 12.00

SALLE DEF
Session 10 |Gestion du stress et de la douleur

MENZRI Murielle , Nancy - France
GUY-MOYAT Benoit, Limoges - France

Rôle IDE /IADE

WARNING Leo , Neuilly-sur-Seine - France

Techniques alternatives, hypnose et casque de réalité virtuelle

MADELAINE Hélène et MORIN Juliette, Caen - France

Quand l’anesthésie générale est-elle nécessaire ?

HAMMACHE Néfissa, Nancy - France

Table Ronde

12.00 - 13.00

SALLE DEF
Session 11 | Et vos centres ? : présentez-vous ? Votre spécificité ? Écoresponsable ?

NIRO Marjorie, Saint-Denis - France
MANSOURATI Jacques, Brest - France
ROUZET Alexia, Monfermeil - France

Hôpital public en Italie

BATTAGLIA Alberto, Asti – Italie

CHU

ALBA Céline et Delphone Munier, Nancy - France

DUBLINEAU Benoit , Valenciennes - France

Table ronde

12.00 - 13.00

SALLE AB
Session 15 | Stereotactic Arrhythmia Radioablation of Ventricular Tachycardia

MAURY Philippe, Toulouse - France
PEICHL Petr, Prague - Czech Republic

Effect of SBRT on cardiac tissue and its evolution overtime

JADCZYK Thomasz, Kravow - Poland

Pitfalls of target identification

POSTEMA Pieter, Amsterdam - Netherlands

Semi-automatic target identification

COCHET Hubert, Bordeaux - France

Stopstorm consortium

PRUVOT Etienne, Lausanne - Switzerland

Discussion

13.00 - 13.45

STUDIO B
Interpretation of on-board electrograms

Part 2: defibrillators

COMBES Stéphane, Toulouse - France

13.45 - 14.45

SALLE AB
Session 16 | Tools to identify and treat difficult PVCs

HOCINI Meleze, Bordeaux - France
LELLOUCHE Nicolas, Paris - France

Localisation of PVC via noninvasive tools

MARCHLINSKI Frank, Philadelphia - USA

PVC ablation via coronary venous system

LE POLAIN de WAROUX Jean-Benoit, Bruges - Belgium

Implication of anatomy of papillary muscle connections for mapping and ablation of focal VA

BOGUN Frank, Ann Arbor - USA

ICE for PVC ablation, more than a localization tool? (contact, scar, Insight on energy effect)

PEICHL Petr, Prague - Czech Republic

Round Table

14.00 - 15.00

SALLE DEF
Session 12 | Évolutions professionnelles

CUSSONNEAU Maryse , Saint-Brieuc - France
MAGNIN POULL Isabelle , Nancy - France

DU de télé cardiologie

LAQUEBE Melissa et STAMMINGER Claire , Bordeaux - France

Formation hypnose et plus-value

BRIDET Julie et GUERINET Séverine, Bordeaux - France

Les infirmiers qui partent travailler pour des labos (avantages, inconvénients…)

BOIRE Nelly , Lyon - France

Délégations et perspectives…

METTE Carole, Saint-Denis - France

Table ronde

14.45 - 15.45

SALLE AB
Session 17 | Ventricular fibrillation

PROBST Vincent, Nantes - France
LACOTTE Jérôme, Massy – France

Substrate post myocardial infarction - timing and effect of remodeling to explain post MI ventricular arrhythmias

BERNUS Olivier, Bordeaux - France

Which strategy for VF storm post subacute MI?

MARTINS Raphael, Rennes - France

Purkinje-Related Ventricular Tachycardia and Ventricular Fibrillation: Solved and Unsolved Questions

HOCINI Meleze, Bordeaux - France

Ablation of Brugada Syndrome? Are we ready for earlier indication

SACHER Frederic, Bordeaux - France

Round Table

15.45 - 15.50

Conclusion

HOCINI Mélèze, Bordeaux - France

DE CHIILLOU Christian , Nancy - France

Type of sessions / Type de ...

Medical program / Programme médecins

Paramedical program / Programme Paramedical

Retac’s workshops / Atelier RETAC

Medical program / Programme ...

Session 1 | 2024 AF ablation guidelines: what is new? And what remains to be determined

COMBES Stephane
DEFAYE Pascal

Risk factors and preprocedural management
PIOT Olivier, Saint-Denis - France

Indications and strategies in AF ablation
HOCINI Meleze, Bordeaux - France

Technical consideration
BOVEDA Serge, Toulouse - France

Post-procedural management
SELLAL Jean-Marc, Nancy - France

Discussion
SALLE AB
mercredi 14.00 - 15.00
Session 2 | AF and brain

FRONTERA Antonio
JAIS Pierre

Cerebral conditions/modifications associated with AF
SIBON Igor, Bordeaux - France

Could we do better than CHADSVASC2 ? RHU TALENT
DUCHATEAU Josselin, Bordeaux - France

Silent brain infarcts and cognitive decline, the Swiss AF study
KRISAI Philipp, Basel - Switzerland

Silent cerebral events during ablation, role of energy and strategies for risk reduction
De POTTER Tom, Leuven - Belgium

Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation
KATO Takeshi, Kanazawa - Japan

Is AF ablation likely to help reducing AF associated cognitive decline?
RIVARD Lena, Montreal - Canada

Discussion
SALLE AB
mercredi 15.00 - 16.30
Session 3 | AF ablation

KNECHT Sebastien
REKVAVA Roin

Can AI based algorithms help selecting patients for long standing AF ablation?
WILLIAMS Steven, London - United-Kingdom

AF ablation should be offered to asymptomatic patients: - Pro
WILLEMS Stephan, Hamburg - Germany

AF ablation should be offered to asymptomatic patients: -Con
EXTRAMIANA Fabrice, Paris - France

Same day discharge (AF ablation program) - Pro
VOGLER Julia, Hamburg - Germany

Same day discharge (AF ablation program) - Con
FRONTERA Antonio, Milan - Italy

Discussion
SALLE AB
mercredi 17.00 - 18.15
Session 4 | Persistent AF Ablation

ALBENQUE Jean Paul
ANTER Elad
MARTIN Claire

Are current mapping electrodes good enough?
SPECTOR Peter, Vermont - USA

Is there a Functional Substrate for AF
FRONTERA Antonio , Milan - Italy

Targeting scar/low voltage for persistent AF
ARENTZ Thomas, Freiburg - Germany

Electrogram based approach for persistent AF
SEITZ Julien, Marseille - France

Anatomical approach for persistent AF
DERVAL Nicolas, Bordeaux - France

Hybrid approach for AF Ablation
PORTA-SANCHEZ Andreu, Barcelona - Spain

Round Table
SALLE AB
jeudi 08.00 - 09.30
Session 5 | Everything you need to know about PFA

COMBES Stéphane
SCHERR Daniel

Understanding the different PFA solution
KORUTH Jacob, New York - USA

General anesthesia vs sedation?
GUNAWERDENE Melanie, Hamburg - Germany

Demonstrated benefits and real life studies
ANSELME Frederic, Rouen - France

Known and less obvious complications
MAURY Philippe, Toulouse - France

Round Table
SALLE AB
jeudi 09.30 - 10.30
Session 6 | Linear lesions for AF/AT

DERVAL Nicolas
O'NEILL Mark

AT post AF ablation: characteristics, mapping and prognosis
SCHERR Daniel, Graz - Austria

Is an epicardial approach needed and reasonable for linear ablation
JULIA CALVO Justo , Brighton - UK

Non macro reentrant AT: how to handle?
JAIS Pierre, Bordeaux - France

Roof-dependent flutter: where to perform the line ? will PFA simplify it?
PAMBRUN Thomas, Bordeaux - France

Debate: A mitral isthmus line is better than an anterior line : - I prefer a mitral isthmus line
KNECHT Sebastien, Bruges - Belgium

Debate: A mitral isthmus line is better than an anterior line : - I prefer anterior line
SARKOZY Andrea, Brussels - Belgium

Discussion
SALLE AB
jeudi 11.00 - 12.15
Session 7 | Sustainability in cardiac electrophysiology

CHAMP RIGOT Laure
MEYER Christian

What are the potential risks/limits associated with reuse and how to avoid them?
LE POLAIN de WAROUX Jean-Benoit, Bruges - Belgium

Value of remote vs in-house support for EP procedure
TILZ Roland, Luebeck - Germany

Industrial perspective
IHARA Zenichi, Abbott - BROOK Clare, Boston Scientific – BASU Shubhayu, Biosense Webster – POWELL David, Medtronic – VAHLE Viola, Vanguard,

Round Table
SALLE AB
jeudi 13.15 - 14.20
Session 8 | Treatment of cardiac arrhythmias in specific conditions

JADCZYK Tomasz
JESEL MOREL Laurence

Anti-arythmic effect of HF drugs
WIEDMANN Felix, Heidelberg - Germany

AF ablation in HF with reduced/preserved EF
O'NEILL Louisa, Dublin - Ireland

AF ablation in inherited conditions
GANDJBAKHCH Estelle , Paris - France

Catheter ablation vs drugs in HF patients
BENALI Karim, Saint-Etienne - France

Round Table
SALLE AB
jeudi 14.20 - 15.20
Session 9 | Sudden cardiac death prediction

ALIOT Etienne
MABO Philippe
TILZ Roland

How SCD registries may help for SCD prevention
GARCIA Rodrigue, Poitiers - France

Can AI predict SCD?
DUBOIS Rémi, Bordeaux - France

Insight from PROFID registries
DAGRES Nikolaos, Berlin - Germany

Prediction of SCD underlying substrate by VF characteristics on ICD
HAISSAGUERRE Michel , Bordeaux - France

Round Table
SALLE AB
jeudi 15.50 - 16.50
Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system

DEHARO Jean Claude
FRONTERA Antonio

Interaction of autonomic nervous system and heart
SIPIDO Karin, Leuven - Belgium

Percutaneous sympathetic blockade for electrical storm
CLEQUIN Etienne, Bordeaux - France

Influence of neuromodulation on ventricular arrhythmias
BUCKLEY Una, Dublin - Ireland

Cardio neuromodulation indication and target
AKSU Tolga, Istanbul - Turkey

Cardioneuromodulation for functional AV block
REKVAVA Roin, Tbilisi - Georgie

Live in a box
DUCHATEAU Josselin , Bordeaux - France

Discussion
SALLE AB
jeudi 16.50 - 18.00
Session 11 | Arrhythmia in Congenital Heart Disease

DERVAL Nicolas
MALTRET Alice

Surgical input of main congenital cardiac surgery and potential implication for arrhythmia
COMBES Nicolas, Toulouse - France

How imaging can improve the ablation procedure?
SACHER Frederic, Bordeaux - France

Ablation in TOF patients, can we avoid ICDs?
WALLET Justin, Leiden - Netherland

Live in a box
WALDMANN Victor, Paris - Fance

Round Table
SALLE AB
jeudi 18.00 - 19.00
Session 12 | Unusual treatment for VT

DE CHIILLOU Christian
KORUTH Jacob

Regeneration of the tissue is better than destroying it
ADELINO Raquel, Barcelona - Spain

VT from septal Substrate How to recognize and treat it?
MARCHLINSKI Francis, Philadelphia - USA

What can we expect from PFA in the ventricle
ANTER Elad, Tel Aviv - Israel

Live in a box / PFA for VT ablation
SACHER Frederic, Bordeaux - France

Live in a box - Ultra Low Cryo ablation
TILZ Roland, Lübeck - Germany

Round Table
SALLE AB
vendredi 08.15 - 09.30
Session 13 | Assessing the substrate of ventricular arrhythmia

MARCHLINSKI Frank
PORTA SANCHEZ Andreu

Substrate Mapping for Ventricular Tachycardia: Assumptions and Misconceptions
ANTER Elad, Tel Aviv - Israel

Can imaging identify VT circuit?
JAIS Pierre, Bordeaux - France

MRI to predict VT occurrence
DE CHIILLOU Christian , Nancy - France

Imaging guidance or functional mapping of the ventricular substrate, how to integrate them in an easy way?
ROCA-LUQUE Ivo, Barcelona - Spain

Round Table
SALLE AB
vendredi 09.30 - 10.30
Session 14 | What is beyond bipolar depolarization mapping for ventricular arrhythmias

ANTER Elad
MARTINS Raphael

How to assess ventricular repolarization in humans
CORONEL Ruben, Amsterdam - Netherland

How to best define VT substrate/ circuit using different tools? Unipolar/bipolar EGM, omnipolar/ near-field technology or repolarization
PORTA SANCHEZ Andreu, Barcelona - Spain

Ventricular substrate assessment, Should I do it during SR, RV pacing or ES?
MARTIN Claire, Cambridge - UK

Discussion
SALLE AB
vendredi 11.00 - 12.00
Session 15 | Stereotactic Arrhythmia Radioablation of Ventricular Tachycardia

MAURY Philippe
PEICHL Petr

Effect of SBRT on cardiac tissue and its evolution overtime
JADCZYK Thomasz, Kravow - Poland

Pitfalls of target identification
POSTEMA Pieter, Amsterdam - Netherlands

Semi-automatic target identification
COCHET Hubert, Bordeaux - France

Stopstorm consortium
PRUVOT Etienne, Lausanne - Switzerland

Discussion
SALLE AB
vendredi 12.00 - 13.00
Session 16 | Tools to identify and treat difficult PVCs

HOCINI Meleze
LELLOUCHE Nicolas

Localisation of PVC via noninvasive tools
MARCHLINSKI Frank, Philadelphia - USA

PVC ablation via coronary venous system
LE POLAIN de WAROUX Jean-Benoit, Bruges - Belgium

Implication of anatomy of papillary muscle connections for mapping and ablation of focal VA
BOGUN Frank, Ann Arbor - USA

ICE for PVC ablation, more than a localization tool? (contact, scar, Insight on energy effect)
PEICHL Petr, Prague - Czech Republic

Round Table
SALLE AB
vendredi 13.45 - 14.45
Session 17 | Ventricular fibrillation

PROBST Vincent
LACOTTE Jérôme

Substrate post myocardial infarction - timing and effect of remodeling to explain post MI ventricular arrhythmias
BERNUS Olivier, Bordeaux - France

Which strategy for VF storm post subacute MI?
MARTINS Raphael, Rennes - France

Purkinje-Related Ventricular Tachycardia and Ventricular Fibrillation: Solved and Unsolved Questions
HOCINI Meleze, Bordeaux - France

Ablation of Brugada Syndrome? Are we ready for earlier indication
SACHER Frederic, Bordeaux - France

Round Table
SALLE AB
vendredi 14.45 - 15.45

Paramedical program / ...

Session 1 |Les explorations électrophysiologiques endocavitaires

FAUCHIER Laurent
METTE Carole

Notions d’anatomie/physiologie pour comprendre la rythmologie
ECHIVARD Mathieu, Nancy - France

Quand et pourquoi demander une exploration ? (indications, réalisation pratique)
DAVRIL Clement, Nancy - France

Interprétation des signaux endocavitaires (en se basant sur des exemples concrets)
BEHAGHEL Albin, Angers - France

L’IDE en salle pendant une exploration
JUND Beatrice, Strasbourg - France

L’IDE en salle pendant une exploration
Benedicte MURER, Strasbourg - France

Table ronde

SALLE DEF
mercredi 14.00 - 15.00
Session 2 | Les ablations de tachycardies supraventriculaires

DA COSTA Antoine
QUINQUIS Elisa

TRIN
HAGER François Xavier , Avignon - France

Voie accessoire
NINNI Sandro, Lille - France

Flutter atrial
JESEL MOREL Laurence, Strasbourg - France

QUIZ
BENALI Karim, Saint-Etienne - France

Table ronde

SALLE DEF
mercredi 15.00 - 16.00
Session 3 | Troubles du rythme ventriculaire

SORIO Delphine
WAINTRAUB Xavier

ESV quand proposer une ablation et comment la pratiquer ?
MANENTI Vladimir, Massy - France

Ablation de TV sur cardiopathie ischémique (indication, différentes stratégies substrat vs circuit)
FATEMI Marjaneh, Brest - France

Ablation de TV sur cardiopathie non-ischémique ou coeur sain
LESAFFRE François, Reims - France

Ablation de TV par voie épicardique (indication, complication)
PETIT Karine, Tours - France

L’IDE en salle pendant l’ablation de TV
FRANCO Sarah et MUNARETTO Cyrielle, Toulouse - France

Table ronde

SALLE DEF
mercredi 16.30 - 18.00
Session 4 | Se repérer / se guider : travail en collaboration IDE / ingénieur d’application

FINOT Emilie
PASQUIE Jean-Luc

En scopie / en ETO / en écho intra cardiaque
AMRAOUI Sana, Paris - France

Impact des rayonnements ionisants sur le personnel de santé
SELLAL Jean Marc, Nancy - France

Système CARTO
MENZRI Murielle et TISSIER Maxime, Nancy - France

Système ENSITE X
KHAMMAR Fatima - MONTOYA Thibaut et PIDOUX Isabelle, Bordeaux - France

Système RHYTHMIA
GUIBERT Jimmy et MOREAU Thomas, Le Mans et Voisins le Bretonneux - France

Table Ronde

SALLE DEF
jeudi 09.00 - 10.30
Session 5 | Les différentes énergies : travail en collaboration IDE / médecin

ALBA Céline
CHEVALIER Philippe

Radiofréquence
LATCU Gabriel et BRUN Caroline, Monaco - France

Cryoablation
SOCIE Pierre et PIGRENIER Daphné, Chartre - France

Electroporation
REYNAUD Nicolas et DENYS Caroline, Reims - France

Table Ronde

SALLE DEF
jeudi 11.00 - 12.30
Session 6 | Pédiatrie, cardiopathie congénitale et canalopathie

MALTRET Alice
ZITOUNI TERKI Meriem

Troubles du rythme chez l’enfant : quelques pathologies responsables d’arythmies (T4F, fermeture de CIA…)
SACRISTAN Benjamin , Bordeaux - France

Prise en charge spécifique de l’enfant : quand ablater, quelques exemples d’arythmies.
GIRAULT Mélanie et MORENO Olivia , Paris - France

Syndrome de BRUGADA : test à l’ajmaline et ablation : chez qui ? quand ? comment ?
GOURRAUD Jean-Baptiste, Nantes - France

QUIZ
GUENANCIA Charles , Dijon - France

Table ronde

SALLE DEF
jeudi 13.30 - 14.30
Session 7 | Ambulatoire

ARTIGUES Laurence
CLEMENTY Nicolas
KLUG Didier

Pour quels types de procédure ? Exploration, ablation, tests médicamenteux
EL BOUAZZAOUI Rim , Libourne - France

Organisation d’un centre
GUELTON Marion et ROGE PICARD Franck , Rouen - France

Ablation de FA en ambulatoire ?
MONTASSIR Safa , Paris - Fance

Table ronde

SALLE DEF
jeudi 14.30 - 15.30
Session 8 | La FA

FOURNIER Nathalie
KUBALA Mathieu

Les différents types de FA (définitions, mécanisme, impact…)
LAURENT Gabriel , Dijon - France

Ablation : quelle stratégie pour la parox / la persistante ?
BUN Sok-Sithikun, Nice - France

Pourquoi avons-nous toujours plus de patients à ablater ?
LEPILLIER Antoine, Paris - France

L’IDE en salle pendant l’ablation sous anesthésie locale / générale
BOURRAT Cédric et SABATIER Céline , Caen - France

Table ronde

SALLE DEF
jeudi 16.00 - 17.00
Session 09 | Gestion des complications

METTE Carole
EXTRAMIANA Fabrice
TAIEB Jérôme

BAV complet
DEVROE Simon et VERDIN Anne Charlotte, Lomme - France

Tamponnade
GUIBERT Jimmy , Le Mans - France

Sus décalage
TIXIER Romain, Bordeaux - France

Hématome/fistule
LELLOUCHE Nicolas , Paris - France

ACR
MASSOULLIE Grégoire , Clermont-Ferrand - France

Quiz ECG
METTE Carole, Saint-Denis - France

Table ronde

SALLE DEF
vendredi 09.00 - 10.30
Session 10 |Gestion du stress et de la douleur

MENZRI Murielle
GUY-MOYAT Benoit

Rôle IDE /IADE
WARNING Leo , Neuilly-sur-Seine - France

Techniques alternatives, hypnose et casque de réalité virtuelle
MADELAINE Hélène et MORIN Juliette, Caen - France

Quand l’anesthésie générale est-elle nécessaire ?
HAMMACHE Néfissa, Nancy - France

Table Ronde

SALLE DEF
vendredi 11.00 - 12.00
Session 11 | Et vos centres ? : présentez-vous ? Votre spécificité ? Écoresponsable ?

NIRO Marjorie
MANSOURATI Jacques
ROUZET Alexia

Hôpital public en Italie
BATTAGLIA Alberto, Asti – Italie

CHU
ALBA Céline et Delphone Munier, Nancy - France

CH
DUBLINEAU Benoit , Valenciennes - France

Table ronde

SALLE DEF
vendredi 12.00 - 13.00
Session 12 | Évolutions professionnelles

CUSSONNEAU Maryse
MAGNIN POULL Isabelle

DU de télé cardiologie
LAQUEBE Melissa et STAMMINGER Claire , Bordeaux - France

Formation hypnose et plus-value
BRIDET Julie et GUERINET Séverine, Bordeaux - France

Les infirmiers qui partent travailler pour des labos (avantages, inconvénients…)
BOIRE Nelly , Lyon - France

Délégations et perspectives…
METTE Carole, Saint-Denis - France

Table ronde

SALLE DEF
vendredi 14.00 - 15.00

Retac’s workshops / ...

Interpretation of on-board electrograms

Part 1: pacemakers

BOVEDA Serge, Toulouse - France

Part 1: pacemakers
DEFAYE Pascal, Grenoble - France

STUDIO B
mercredi 16.30 - 17.00
Interpretation of surface ECG traces, fine QRS

COMBES Nicolas, Toulouse - France

VENIER Sandrine, Grenoble - France

STUDIO B
jeudi 10.30 - 11.00
EP study: interpretation of endocavitary tracings

CARRABELLI Adrien , Grenoble - France

GUY MOYAT Benoit , Limoges - France

STUDIO B
jeudi 12.30 - 13.30
Interpretation of 3D maps

COMBES Stéphane, Toulouse - France

GUY MOYAT Benoit , Limoges - France

STUDIO B
jeudi 15.30 - 16.00
Interpretation of 3D maps

VENIER Sandrine , Grenoble - France

VOGLIMACCI Quentin, Toulouse - France

STUDIO B
vendredi 10.40 - 11.00
Interpretation of on-board electrograms

Part 2: defibrillators
COMBES Stéphane, Toulouse - France

STUDIO B
vendredi 13.00 - 13.45

partners / partenaires

https://www.fr.abbott/
1-3 esplanade du Foncet
92442 Issy Les Moulineaux
Stand n^°: 2
https://www.adas3d.com/
Ramba Catalunya, 53
8007 Barcelona, Spain
Stand n^°: 1
https://www.atricure.com/
De Entree 260
1101 EE Amsterdam
Stand n^°:
https://www.jnjmedtech.com/en-US/companies/biosensewebster
1 rue Camille Desmoulins
92787 Issy Les Moulineaux
Stand n^°: 11
https://www.bostonscientific.com/en-US/home.html
2 rue René Caudron
78 960 Voisins Le Bretonneux
Stand n^°: 3
https://www.catheterprecision.com/
1670 Highway 160 W Ste 205
SC 29708 Fort Mill
Stand n^°: 14
https://www.gehealthcare.fr/
1211, Chemin de la Bruyère
69760 Limonest
Stand n^°: 15
https://implicity.com/
15 rue des Halles
75001 Paris
Stand n^°: 12
https://www.inheartmedical.com/
AV DU HAUT LEVEQUE
33600 Pessac
Stand n^°: 6
https://www.ihu-liryc.fr/
Avenue du Haut-Lévêque
33604 Pessac
Stand n^°: 16
https://www.medtronic.com/fr-fr/index.html
9 Boulevard Rolland
75014 Paris
Stand n^°: 10b
https://microport.fr/
4 avenue Réaumur
92140 Clamart
Stand n^°: 10a
https://www.stereotaxis.com/
Zaanweg 67i
1521DM Wormerveer
Stand n^°: 5
https://www.volta-medical.com/
65 Avenue Jules Cantini
13006 Marseille
Stand n^°: 9
https://www.zoll.com/fr
2 rue René Caudron
78 960 Voisins Le Bretonneux
Stand n^°: 4

speakers / conférenciers

AKSU Tolga

Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system
Jeudi 17 octobre 17.00 - 18.00
SALLE AB
ALBA Céline

Et vos centres ??? : présentez-nous ? Votre spécificité ? Ecoresponsable ??
Vendredi 18 octobre 12h00 à 13h00
SALLE DEF
Les différentes énergies : travail en collaboration IDE / médecin
Jeudi 17 octobre 11h00 à 12h30
SALLE DEF
ALBENQUE Jean Paul

Session 4 | Persistent AF Ablation
Jeudi 17 octobre 08.30 - 09.30
SALLE AB
ALIOT Etienne

Session 9 | Sudden cardiac death prediction
Jeudi 17 octobre 16.00 - 17.00
SALLE AB
Opening Ceremony
Mercredi 16 octobre 13.45 - 14.00
AMRAOUI Sana

Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
ANSELME Frederic

Session 5 | All what you need to know on PFA
Jeudi 17 octobre 09.30 - 10.30
SALLE AB
ANTER Elad

Session 12 | Unusual treatment for VT
Vendredi 18 octobre 08.15 - 09.30
SALLE AB
Session 13 | Assessing the substrate of ventricular arrhythmia
Vendredi 18 octobre 09.30 - 10.30
SALLE AB
Session 14 | What is beyond bipolar depolarization mapping for ventricular arrhythmias
Vendredi 18 octobre 11.00 - 12.00
SALLE AB
Session 4 | Persistent AF Ablation
Jeudi 17 octobre 08.00 - 09.30
SALLE AB
ARENTZ Thomas

Session 4 | Persistent AF Ablation
Jeudi 17 octobre 08.00 - 09.30
SALLE AB
ARTIGUES Laurence

Ambulatoire
Jeudi 17 octobre 14h30 à 15h30
SALLE DEF
BASU Shubhayu

Session 7 | Sustainability in cardiac electrophysiology
Jeudi 17 octobre 13.15 - 14.30
SALLE AB
BATTAGLIA Alberto

Et vos centres ??? : présentez-nous ? Votre spécificité ? Ecoresponsable ??
Vendredi 18 octobre 12h00 à 13h00
SALLE DEF
BEHAGHEL Albin

Les explorations électrophysiologiques endocavitaires
Mercredi 16 octobre 14h00 à 15h00
SALLE DEF
BENALI Karim

Session 8 | Treatment of cardiac arrythmias in speciific conditions
Jeudi 17 octobre 14.30 - 15.30
SALLE AB
Les ablations de tachycardies supraventriculaires
Mercredi 16 octobre 15h00 à 16h00
SALLE DEF
BERNUS Olivier

Session 17 | Ventricular fibrillation
Vendredi 18 octobre 14.45 - 15.45
SALLE AB
BOGUN Frank

Session 16 | Tools to identify and treat difficult PVCs
Vendredi 18 octobre 13.45 - 14.45
SALLE AB
BOIRE Nelly

Évolutions professionnelles
Vendredi 18 octobre 14h00 à 15h00
SALLE DEF
BOURRAT Cédric

La FA
Jeudi 17 octobre 16h00 à 17h00
SALLE DEF
BOVEDA Serge

Interpretation of on-board electrograms
Mercredi 16 octobre 16h30 – 17h00
STUDIO F
Session 1 | 2024 AF ablation guidelines: what is new? And what remains to be determined
Mercredi 16 octobre 14.00 - 15.00
SALLE AB
BRIDET Julie

Évolutions professionnelles
Vendredi 18 octobre 14h00 à 15h00
SALLE DEF
BROOK Clare

Session 7 | Sustainability in cardiac electrophysiology
Jeudi 17 octobre 13.15 - 14.30
SALLE AB
BRUN Caroline

Les différentes énergies : travail en collaboration IDE / médecin
Jeudi 17 octobre 11h00 à 12h30
SALLE DEF
BUCKLEY Una

Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system
Jeudi 17 octobre 17.00 - 18.00
SALLE AB
BUN Sok-Sithikun

La FA
Jeudi 17 octobre 16h00 à 17h00
SALLE DEF
CARRABELLI Adrien

EP study: interpretation of endocavitary tracings
Jeudi 17 octobre 12h30 - 13h30
STUDIO F
CHAMP RIGOT Laure

Session 7 | Sustainability in cardiac electrophysiology
Jeudi 17 octobre 13.15 - 14.30
SALLE AB
CHEVALIER Philippe

Les différentes énergies : travail en collaboration IDE / médecin
Jeudi 17 octobre 11h00 à 12h30
SALLE DEF
CLEMENTY Nicolas

Ambulatoire
Jeudi 17 octobre 14h30 à 15h30
SALLE DEF
CLEQUIN Etienne

Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system
Jeudi 17 octobre 17.00 - 18.00
SALLE AB
COCHET Hubert

Session 15 | Stereotactic Arrhythmia Radioablation of Ventricular Tachycardia
Vendredi 18 octobre 12.00 – 13.00
SALLE AB
COMBES Stéphane

Session 5 | All what you need to know on PFA
Jeudi 17 octobre 09.30 - 10.30
SALLE AB
Interpretation of on-board electrograms
Vendredi 18 octobre 13h00 - 13h45
STUDIO F
Session 1 | 2024 AF ablation guidelines: what is new? And what remains to be determined
Mercredi 16 octobre 14.00 - 15.00
SALLE AB
Interpretation of 3D maps
Jeudi 17 octobre 15h30 - 16h00
STUDIO F
COMBES Nicolas

Interpretation of surface ECG traces, fine QRS
Jeudi 17 octobre 10h30 - 11h00
STUDIO F
Session 11 | Arrhythmia in Congenital Heart Disease
Jeudi 17 octobre 18.00 - 19.00
SALLE AB
CORONEL Ruben

Session 14 | What is beyond bipolar depolarization mapping for ventricular arrhythmias
Vendredi 18 octobre 11.00 - 12.00
SALLE AB
CUSSONNEAU Maryse

Évolutions professionnelles
Vendredi 18 octobre 14h00 à 15h00
SALLE DEF
DA COSTA Antoine

Les ablations de tachycardies supraventriculaires
Mercredi 16 octobre 15h00 à 16h00
SALLE DEF
DAGRES Nikolaos

Session 9 | Sudden cardiac death prediction
Jeudi 17 octobre 16.00 - 17.00
SALLE AB
DAVRIL Clement

Les explorations électrophysiologiques endocavitaires
Mercredi 16 octobre 14h00 à 15h00
SALLE DEF
DE CHIILLOU Christian

Session 12 | Unusual treatment for VT
Vendredi 18 octobre 08.15 - 09.30
SALLE AB
Session 13 | Assessing the substrate of ventricular arrhythmia
Vendredi 18 octobre 09.30 - 10.30
SALLE AB
Conclusion
Vendredi 18 octobre 15.45 - 15.50

Opening Ceremony
Mercredi 16 octobre 13.45 - 14.00
DE POTTER Tom

Session 2 | AF and brain
Mercredi 16 octobre 15.00 - 16.30
SALLE AB
DEFAYE Pascal

Interpretation of on-board electrograms
Mercredi 16 octobre 16h30 – 17h00
STUDIO F
Session 1 | 2024 AF ablation guidelines: what is new? And what remains to be determined
Mercredi 16 octobre 14.00 - 15.00
SALLE AB
DEHARO Jean Claude

Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system
Jeudi 17 octobre 17.00 - 18.00
SALLE AB
DENYS Caroline

Les différentes énergies : travail en collaboration IDE / médecin
Jeudi 17 octobre 11h00 à 12h30
SALLE DEF
DERVAL Nicolas

Session 4 | Persistent AF Ablation
Jeudi 17 octobre 08.00 - 09.30
SALLE AB
Session 11 | Arrhythmia in Congenital Heart Disease
Jeudi 17 octobre 18.00 - 19.00
SALLE AB
Session 6 | Linear lesions for AF/AT
Jeudi 17 octobre 11.00 - 12.15
SALLE AB
DEVROE Simon

Gestion des complications
Vendredi 18 octobre 09h00 à 10h30
SALLE DEF
DUBLINEAU Benoit

Et vos centres ??? : présentez-nous ? Votre spécificité ? Ecoresponsable ??
Vendredi 18 octobre 12h00 à 13h00
SALLE DEF
DUBOIS Rémi

Session 9 | Sudden cardiac death prediction
Jeudi 17 octobre 16.00 - 17.00
SALLE AB
DUCHATEAU Josselin

Session 2 | AF and brain
Mercredi 16 octobre 15.00 - 16.30
SALLE AB
Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system
Jeudi 17 octobre 17.00 - 18.00
SALLE AB
ECHIVARD Mathieu

Les explorations électrophysiologiques endocavitaires
Mercredi 16 octobre 14h00 à 15h00
SALLE DEF
EL BOUAZZAOUI Rim

Ambulatoire
Jeudi 17 octobre 14h30 à 15h30
SALLE DEF
EXTRAMIANA Fabice

Session 3 | AF ablation
Mercredi 16 octobre 17.00 - 18.15
SALLE AB
Gestion des complications
Vendredi 18 octobre 09h00 à 10h30
SALLE DEF
FATEMI Marji

Troubles du rythme ventriculaire
Mercredi 16 octobre 16h30 à 18h00
SALLE DEF
FAUCHIER Laurent

Les explorations électrophysiologiques endocavitaires
Mercredi 16 octobre 14h00 à 15h00
SALLE DEF
FINOT Emilie

Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
FOURNIER Nathalie

La FA
Jeudi 17 octobre 16h00 à 17h00
SALLE DEF
FRANCO Sarah

Troubles du rythme ventriculaire
Mercredi 16 octobre 16h30 à 18h00
SALLE DEF
FRONTERA Antonio

Session 2 | AF and brain
Mercredi 16 octobre 15.00 - 16.30
SALLE AB
Session 3 | AF ablation
Mercredi 16 octobre 17.00 - 18.15
SALLE AB
Session 4 | Persistent AF Ablation
Jeudi 17 octobre 08.00 - 09.30
SALLE AB
Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system
Jeudi 17 octobre 17.00 - 18.00
SALLE AB
GANDJBAKHCH Estelle

Session 8 | Treatment of cardiac arrythmias in speciific conditions
Jeudi 17 octobre 14.30 - 15.30
SALLE AB
GARCIA Rogrigues

Session 9 | Sudden cardiac death prediction
Jeudi 17 octobre 16.00 - 17.00
SALLE AB
GIRAULT Mélanie

Pédiatrie, cardiopathie congénitale et canalopathie
Jeudi 17 octobre 13h30 à 14h30
SALLE DEF
GOURRAUD Jean-Baptiste

Pédiatrie, cardiopathie congénitale et canalopathie
Jeudi 17 octobre 13h30 à 14h30
SALLE DEF
GUELTON Marion

Ambulatoire
Jeudi 17 octobre 14h30 à 15h30
SALLE DEF
GUENANCIA Charles

Pédiatrie, cardiopathie congénitale et canalopathie
Jeudi 17 octobre 13h30 à 14h30
SALLE DEF
GUERINET Sévérine

Évolutions professionnelles
Vendredi 18 octobre 14h00 à 15h00
SALLE DEF
GUIBERT Jimmy

Gestion des complications
Vendredi 18 octobre 09h00 à 10h30
SALLE DEF
Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
GUNAWERDENE Melanie

Session 5 | All what you need to know on PFA
Jeudi 17 octobre 09.30 - 10.30
SALLE AB
GUY MOYAT Benoit

Interpretation of 3D maps
Jeudi 17 octobre 15h30 - 16h00
STUDIO F
EP study: interpretation of endocavitary tracings
Jeudi 17 octobre 12h30 - 13h30
STUDIO F
HAGER François Xavier

Les ablations de tachycardies supraventriculaires
Mercredi 16 octobre 15h00 à 16h00
SALLE DEF
HAISSAGUERRE Michel

Session 9 | Sudden cardiac death prediction
Jeudi 17 octobre 16.00 - 17.00
SALLE AB
HAMMACHE Néfissa

Gestion du stress et de la douleur
Vendredi 18 octobre 11h00 à 12h00
SALLE DEF
HOCINI Meleze

Session 16 | Tools to identify and treat difficult PVCs
Vendredi 18 octobre 13.45 - 14.45
SALLE AB
Session 17 | Ventricular fibrillation
Vendredi 18 octobre 14.45 - 15.45
SALLE AB
Conclusion
Vendredi 18 octobre 15.45 - 15.50

Session 1 | 2024 AF ablation guidelines: what is new? And what remains to be determined
Mercredi 16 octobre 14.00 - 15.00
SALLE AB
IHARA Zenichi

Session 7 | Sustainability in cardiac electrophysiology
Jeudi 17 octobre 13.15 - 14.30
SALLE AB
JADCZYK Thomasz

Session 15 | Stereotactic Arrhythmia Radioablation of Ventricular Tachycardia
Vendredi 18 octobre 12.00 – 13.00
SALLE AB
Session 8 | Treatment of cardiac arrythmias in speciific conditions
Jeudi 17 octobre 14.30 - 15.30
SALLE AB
JAIS Pierre

Session 2 | AF and brain
Mercredi 16 octobre 15.00 - 16.30
SALLE AB
Session 6 | Linear lesions for AF/AT
Jeudi 17 octobre 11.00 - 12.15
SALLE AB
Session 13 | Assessing the substrate of ventricular arrhythmia
Vendredi 18 octobre 09.30 - 10.30
SALLE AB
Opening Ceremony
Mercredi 16 octobre 13.45 - 14.00
JESEL MOREL Laurence

Session 8 | Treatment of cardiac arrythmias in speciific conditions
Jeudi 17 octobre 14.30 - 15.30
SALLE AB
JULIA CALVO Justo

Session 6 | Linear lesions for AF/AT
Jeudi 17 octobre 11.00 - 12.15
SALLE AB
JUND Beatrice

Les explorations électrophysiologiques endocavitaires
Mercredi 16 octobre 14h00 à 15h00
SALLE DEF
KATO Takeshi

Session 2 | AF and brain
Mercredi 16 octobre 15.00 - 16.30
SALLE AB
KHAMMAR Fatima

Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
KLUG Didier

Ambulatoire
Jeudi 17 octobre 14h30 à 15h30
SALLE DEF
KNECHT Sebastien

Session 6 | Linear lesions for AF/AT
Jeudi 17 octobre 11.00 - 12.15
SALLE AB
Session 3 | AF ablation
Mercredi 16 octobre 17.00 - 18.15
SALLE AB
KORUTH Jacob

Session 12 | Unusual treatment for VT
Vendredi 18 octobre 08.15 - 09.30
SALLE AB
Session 5 | All what you need to know on PFA
Jeudi 17 octobre 09.30 - 10.30
SALLE AB
KRISAI Philipp

Session 2 | AF and brain
Mercredi 16 octobre 15.00 - 16.30
SALLE AB
KUBALA Mathieu

La FA
Jeudi 17 octobre 16h00 à 17h00
SALLE DEF
LAQUEBE Melissa

Évolutions professionnelles
Vendredi 18 octobre 14h00 à 15h00
SALLE DEF
LATCU Gabriel

Les différentes énergies : travail en collaboration IDE / médecin
Jeudi 17 octobre 11h00 à 12h30
SALLE DEF
LAURENT Gabriel

La FA
Jeudi 17 octobre 16h00 à 17h00
SALLE DEF
LE POLAIN de WAROUX Jean-Benoit

Session 7 | Sustainability in cardiac electrophysiology
Jeudi 17 octobre 13.15 - 14.30
SALLE AB
Session 16 | Tools to identify and treat difficult PVCs
Vendredi 18 octobre 13.45 - 14.45
SALLE AB
LELLOUCHE Nicolas

Session 16 | Tools to identify and treat difficult PVCs
Vendredi 18 octobre 13.45 - 14.45
SALLE AB
Gestion des complications
Vendredi 18 octobre 09h00 à 10h30
SALLE DEF
LEPILLIER Antoine

La FA
Jeudi 17 octobre 16h00 à 17h00
SALLE DEF
LESAFFRE François

Troubles du rythme ventriculaire
Mercredi 16 octobre 16h30 à 18h00
SALLE DEF
MABO Philippe

Session 9 | Sudden cardiac death prediction
Jeudi 17 octobre 16.00 - 17.00
SALLE AB
MADELAINE Hélène

Gestion du stress et de la douleur
Vendredi 18 octobre 11h00 à 12h00
SALLE DEF
MAGNIN POULL Isabelle

Évolutions professionnelles
Vendredi 18 octobre 14h00 à 15h00
SALLE DEF
MALTRET Alice

Session 11 | Arrhythmia in Congenital Heart Disease
Jeudi 17 octobre 18.00 - 19.00
SALLE AB
Pédiatrie, cardiopathie congénitale et canalopathie
Jeudi 17 octobre 13h30 à 14h30
SALLE DEF
MANENTI Vladimir

Troubles du rythme ventriculaire
Mercredi 16 octobre 16h30 à 18h00
SALLE DEF
MANSOURATI Jacques

Et vos centres ??? : présentez-nous ? Votre spécificité ? Ecoresponsable ??
Vendredi 18 octobre 12h00 à 13h00
SALLE DEF
MARCHLINSKI Francis

Session 12 | Unusual treatment for VT
Vendredi 18 octobre 08.15 - 09.30
SALLE AB
Session 16 | Tools to identify and treat difficult PVCs
Vendredi 18 octobre 13.45 - 14.45
SALLE AB
Session 13 | Assessing the substrate of ventricular arrhythmia
Vendredi 18 octobre 09.30 - 10.30
SALLE AB
MARTIN Claire

Session 4 | Persistent AF Ablation
Jeudi 17 octobre 08.00 - 09.30
SALLE AB
Session 14 | What is beyond bipolar depolarization mapping for ventricular arrhythmias
Vendredi 18 octobre 11.00 - 12.00
SALLE AB
MARTINS Raphael

Session 17 | Ventricular fibrillation
Vendredi 18 octobre 14.45 - 15.45
SALLE AB
Session 14 | What is beyond bipolar depolarization mapping for ventricular arrhythmias
Vendredi 18 octobre 11.00 - 12.00
SALLE AB
MASSOULLIE Grégoire

Gestion des complications
Vendredi 18 octobre 09h00 à 10h30
SALLE DEF
MAURY Philippe

Session 5 | All what you need to know on PFA
Jeudi 17 octobre 09.30 - 10.30
SALLE AB
Session 15 | Stereotactic Arrhythmia Radioablation of Ventricular Tachycardia
Vendredi 18 octobre 12.00 – 13.00
SALLE AB
MENZRI Murielle

Gestion du stress et de la douleur
Vendredi 18 octobre 11h00 à 12h00
SALLE DEF
Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
METTE Carole

Gestion des complications
Vendredi 18 octobre 09h00 à 10h30
SALLE DEF
Évolutions professionnelles
Vendredi 18 octobre 14h00 à 15h00
SALLE DEF
Les explorations électrophysiologiques endocavitaires
Mercredi 16 octobre 14h00 à 15h00
SALLE DEF
MEYER Christian

Session 7 | Sustainability in cardiac electrophysiology
Jeudi 17 octobre 13.15 - 14.30
SALLE AB
MONTASSIR Safa

Ambulatoire
Jeudi 17 octobre 14h30 à 15h30
SALLE DEF
MONTOYA Thibault

Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
MOREAU Thomas

Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
jeudi 17 octobre 2025 09h00 à 10h30
SALLE DEF
MORENO Olivia

Pédiatrie, cardiopathie congénitale et canalopathie
Jeudi 17 octobre 13h30 à 14h30
SALLE DEF
MORIN Juliette

Gestion du stress et de la douleur
Vendredi 18 octobre 11h00 à 12h00
SALLE DEF
MUNARETTO Cyrielle

Troubles du rythme ventriculaire
Mercredi 16 octobre 16h30 à 18h00
SALLE DEF
MUNIER MARCHAL Delphine

Et vos centres ??? : présentez-nous ? Votre spécificité ? Ecoresponsable ??
Vendredi 18 octobre 12h00 à 13h00
SALLE DEF
MURER Benedicte

Les explorations électrophysiologiques endocavitaires
Mercredi 16 octobre 14h00 à 15h00
SALLE DEF
NINNI Sandro

Les ablations de tachycardies supraventriculaires
Mercredi 16 octobre 15h00 à 16h00
SALLE DEF
NIRO Marjorie

Et vos centres ??? : présentez-nous ? Votre spécificité ? Ecoresponsable ??
Vendredi 18 octobre 12h00 à 13h00
SALLE DEF
O'NEILL Louisa

Session 8 | Treatment of cardiac arrythmias in speciific conditions
Jeudi 17 octobre 14.30 - 15.30
SALLE AB
O'NEILL Mark

Session 6 | Linear lesions for AF/AT
Jeudi 17 octobre 11.00 - 12.15
SALLE AB
PAMBRUN Thomas

Session 6 | Linear lesions for AF/AT
Jeudi 17 octobre 11.00 - 12.15
SALLE AB
PASQUIE Jean-Luc

Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
PEICHL Petr

Session 16 | Tools to identify and treat difficult PVCs
Vendredi 18 octobre 13.45 - 14.45
SALLE AB
Session 15 | Stereotactic Arrhythmia Radioablation of Ventricular Tachycardia
Vendredi 18 octobre 12.00 – 13.00
SALLE AB
PETIT Karine

Troubles du rythme ventriculaire
Mercredi 16 octobre 16h30 à 18h00
SALLE DEF
PIDOUX Isabelle

Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
PIGRENIER Daphné

Les différentes énergies : travail en collaboration IDE / médecin
Jeudi 17 octobre 11h00 à 12h30
SALLE DEF
PIOT Olivier

Session 1 | 2024 AF ablation guidelines: what is new? And what remains to be determined
Mercredi 16 octobre 14.00 - 15.00
SALLE AB
PORTA SANCHEZ Andreu

Session 14 | What is beyond bipolar depolarization mapping for ventricular arrhythmias
Vendredi 18 octobre 11.00 - 12.00
SALLE AB
Session 13 | Assessing the substrate of ventricular arrhythmia
Vendredi 18 octobre 09.30 - 10.30
SALLE AB
Session 4 | Persistent AF Ablation
Jeudi 17 octobre 08.00 - 09.30
SALLE AB
POSTEMA Pieter

Session 15 | Stereotactic Arrhythmia Radioablation of Ventricular Tachycardia
Vendredi 18 octobre 12.00 – 13.00
SALLE AB
PROBST Vincent

Session 17 | Ventricular fibrillation
Vendredi 18 octobre 14.45 - 15.45
SALLE AB
PRUVOT Etienne

Session 15 | Stereotactic Arrhythmia Radioablation of Ventricular Tachycardia
Vendredi 18 octobre 12.00 – 13.00
SALLE AB
QUINQUIS Elisa

Les ablations de tachycardies supraventriculaires
Mercredi 16 octobre 15h00 à 16h00
SALLE DEF
REKVAVA Roin

Session 3 | AF ablation
Mercredi 16 octobre 17.00 - 18.15
SALLE AB
Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system
Jeudi 17 octobre 16.50-18.00
SALLE AB
REYNAUD Nicolas

Les différentes énergies : travail en collaboration IDE / médecin
Jeudi 17 octobre 11h00 à 12h30
SALLE DEF
RIVARD Lena

Session 2 | AF and brain
Mercredi 16 octobre 15.00 - 16.30
SALLE AB
ROCA-LUQUE Ivo

Session 13 | Assessing the substrate of ventricular arrhythmia
Vendredi 18 octobre 09.30 - 10.30
SALLE AB
ROGE PICARD Franck

Ambulatoire
Jeudi 17 octobre 14h30 à 15h30
SALLE DEF
ROUZET Alexia

Et vos centres ??? : présentez-nous ? Votre spécificité ? Ecoresponsable ??
Vendredi 18 octobre 12h00 à 13h00
SALLE DEF
SABATIER Céline

La FA
Jeudi 17 octobre 16h00 à 17h00
SALLE DEF
SACHER Frederic

Session 12 | Unusual treatment for VT
Vendredi 18 octobre 08.15 - 09.30
SALLE AB
Session 17 | Ventricular fibrillation
Vendredi 18 octobre 14.45 - 15.45
SALLE AB
Session 11 | Arrhythmia in Congenital Heart Disease
Jeudi 17 octobre 18.00 - 19.00
SALLE AB
SACRISTAN Benjamin

Pédiatrie, cardiopathie congénitale et canalopathie
Jeudi 17 octobre 13h30 à 14h30
SALLE DEF
SARKOZY Andrea

Session 6 | Linear lesions for AF/AT
Jeudi 17 octobre 11.00 - 12.15
SALLE AB
SCHERR Daniel

Session 5 | All what you need to know on PFA
Jeudi 17 octobre 09.30 - 10.30
SALLE AB
Session 6 | Linear lesions for AF/AT
Jeudi 17 octobre 11.00 - 12.15
SALLE AB
SEITZ Julien

Session 4 | Persistent AF Ablation
Jeudi 17 octobre 08.00 - 09.30
SALLE AB
SELLAL Jean Marc

Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
Session 1 | 2024 AF ablation guidelines: what is new? And what remains to be determined
Mercredi 16 octobre 14.00 - 15.00
SALLE AB
SIBON Igor

Session 2 | AF and brain
Mercredi 16 octobre 15.00 - 16.30
SALLE AB
SIPIDO Karen

Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system
Jeudi 17 octobre 17.00 - 18.00
SALLE AB
SOCIE Pierre

Les différentes énergies : travail en collaboration IDE / médecin
Jeudi 17 octobre 11h00 à 12h30
SALLE DEF
SORIO Delphine

Troubles du rythme ventriculaire
Mercredi 16 octobre 16h30 à 18h00
SALLE DEF
SPECTOR Peter

Session 4 | Persistent AF Ablation
Jeudi 17 octobre 08.00 - 09.30
SALLE AB
STAMMINGER Claire

Évolutions professionnelles
Vendredi 18 octobre 14h00 à 15h00
SALLE DEF
TAIEB Jérôme

Gestion des complications
Vendredi 18 octobre 09h00 à 10h30
SALLE DEF
TILZ Roland

Session 9 | Sudden cardiac death prediction
Jeudi 17 octobre 16.00 - 17.00
SALLE AB
Session 12 | Unusual treatment for VT
Vendredi 18 octobre 08.15 - 09.30
SALLE AB
Session 3 | AF ablation
Mercredi 16 octobre 17.00 - 18.15
SALLE AB
TISSIER Maxime

Se repérer / se guider : travail en collaboration IDE / ingénieur d’application
Jeudi 17 octobre 09h00 à 10h30
SALLE DEF
TIXIER Romain

Gestion des complications
Vendredi 18 octobre 09h00 à 10h30
SALLE DEF
VAHLE Viola

Session 7 | Sustainability in cardiac electrophysiology
Jeudi 17 octobre 13.15 - 14.30
SALLE AB
VENIER Sandrine

Interpretation of surface ECG traces, fine QRS
Jeudi 17 octobre 10h30 - 11h00
STUDIO F
Interpretation of 3D maps
Vendredi 18 octobre 10h40 - 11h00
STUDIO F
VERDIN Charlotte

Gestion des complications
Vendredi 18 octobre 09h00 à 10h30
SALLE DEF
VOGLER Julia

Session 7 | Sustainability in cardiac electrophysiology
Jeudi 17 octobre 13.15 - 14.30
SALLE AB
VOGLIMACCI Quentin

Interpretation of 3D maps
Vendredi 18 octobre 10h40 - 11h00
STUDIO F
WAINTRAUB Xavier

Troubles du rythme ventriculaire
Mercredi 16 octobre 16h30 à 18h00
SALLE DEF
WALDMAN Victor

Session 11 | Arrhythmia in Congenital Heart Disease
Jeudi 17 octobre 18.00 - 19.00
SALLE AB
WALLET Justin

Session 11 | Arrhythmia in Congenital Heart Disease
Jeudi 17 octobre 18.00 - 19.00
SALLE AB
WARNING Leo

Gestion du stress et de la douleur
Vendredi 18 octobre 11h00 à 12h00
SALLE DEF
WIEDMANN Felix

Session 8 | Treatment of cardiac arrythmias in speciific conditions
Jeudi 17 octobre 14.30 - 15.30
SALLE AB
WILLEMS Stephan

Session 3 | AF ablation
Mercredi 16 octobre 17.00 - 18.15
SALLE AB
WILLIAMS Steven

Session 3 | AF ablation
Mercredi 16 octobre 17.00 - 18.15
SALLE AB
ZITOUNI TERKI Meriem

Pédiatrie, cardiopathie congénitale et canalopathie
Jeudi 17 octobre 13h30 à 14h30
SALLE DEF

Exhibition map / Plan ...

poster

POSTER n° 01 : Impact of Catheter Ablation of Electrical Storm on Survival in patients with Structural Heart Disease: A Propensity Score Matched Analysis
Ablation of ventricular arrhythmias K.Benali R.Mohammed S.Ninni C.Guenancia P.Jais K.Vlachos M.Haissaguerre R.Martins A.Da Costa

Introduction
Electrical storm (ES) is a life-threatening condition, associated with substantial early and subacute mortality. Catheter ablation (CA) is a well-established therapy for the management of ES. However, data regarding the impact of CA on short- and mid-term survival of patients admitted for ES remains unclear. This multicenter study aimed at investigating the impact of CA of ES on survival outcomes, while accounting for key patient characteristics associated with treatment selection.

Methods
A propensity score (PS) matching (PSM) analysis was performed in 780 consecutive patients admitted for ES in four tertiary centers. PSM (1:1) based on main characteristics associated with the use of CA or medical therapy alone was performed, resulting in two groups of 288 patients.

Results
After PSM, patients who underwent CA (n=288) and patients treated with medical therapy (n=288) did not present any significant difference regarding main demographical characteristics and ES management. Compared to medical therapy alone, CA was associated with a significantly lower rate of ES recurrence at one year (5% vs 26%, p<0.001). Similarly, CA was associated with a higher 1-year (91% vs 81%, p<0.001) and 3-year (78% vs 71 %, p=0.017) survival after discharge. In subgroup analyses, effect of ablation therapy remained consistent in patients older than 70yo (HR 0.39, 95%CI 0.24-0.66), with substantial efficacy in patients with LVEF<35% (HR 0.39, 95%CI 0.27-0.59).

Conclusion
In propensity-matched analyses, this study shows that CA-based management of patients admitted for ES is associated with a reduction in mortality compared to medical therapy alone, particularly in patients with low ejection fraction.
POSTER n° 02 : Biatrial ablation ablation for persistent atrial fibrillation
Ablation of atrial fibrillation K.Jun M.Cha M.Cho G.Nam K.Choi

Introduction
We evaulated feasibility of simplied catheter linear right atrial ablation and 1 year outcome of atrial fibrillation-free survival in patients with persistent atrial fibrillation.

Methods
This prospective, single-center, single-arm trial enroled patients with persistent AF. Procedures included pulmonary vein isolation and simplified right atrial linear ablation (cavotricuspid isthmus ablation, intercaval linear ablation, and superior vena cava isolation). Conduction block across the intercaval line was confirmed by electrical unexcitability, activation detour and differential pacing.

Results
Of 97 patients (64% male, mean age 63 years, mean AF duration 3.1 years) enrolled; RA ablation was feasible in 91 (93.8%) patients. The average procedure and ablation time were 3.1 hours and 48.9 minutes, respectively. At 1-year 19 (19.6%) patients experienced AF recurrence. AThe primary safety endpoint included 1 case of pseudoaneurysm of the femoral vein, 1 transient sick sinus syndrome and 1 case of acute pericarditis.

Conclusion
Biatrial ablation with endpoint of block was safe and effective.
POSTER n° 03 : Pulmonary veins isolations with PVAC Gold in elderly patients.
Ablation of atrial fibrillation L.Behrmann Martins C.Faria Pisani F.K. Dorfman F.C.Costa Darrieux A.Pereira Ferraz T.Chen Wu L.Vergara Ferraz De Souza D.Tessariol Hachul L.Sacilotto C.Pedroso Balbo M.Ibrahim Scanavacca

Introduction
Aim to compare the clinical results of pulmonary vein (PV) isolation with the second-generation PVAC Gold catheter against AA treatment in elderly people with recurrent symptomatic paroxysmal AF.

Methods
60 patients with paroxysmal AF ? 65 years old were randomized to 2 forms of treatment: group 1: CA and group 2: AA drugs. The primary outcome was the AF recurrence-free rate after at least one year of follow-up. Others were progression to persistent forms of AF, impact on quality of life (QOLF) and complications. It used p<0.05.

Results
The AF recurrence-free rate was 80% (10% with amiodarone) in the CA group, after 1.3 procedures per patient and 65% in the AA group (60% with amiodarone), (P = 0.119) in an average follow-up of 719 days (Q1: 566; Q3: 730). The persistent AF free rate was 83.4% in the AC group and 67.7% in the AA group (P = 0.073) Both strategies showed an improvement in the AFQoL score during follow-up (P < 0.001), with no difference between the groups.

Conclusion
Both strategies for maintaining sinus rhythm promoted an improvement in the QOLF of elderly patients with symptomatic AF, with no statistical difference in the clinical outcomes.
POSTER n° 04 : Outcomes of Catheter Ablation in Ventricular Tachycardia Patients with Ischemic and Nonischemic Cardiomyopathy
Ablation of ventricular arrhythmias R.Khosravi F.Kamali S.Simiary M.Hadavi M.Haghjoo A.Fazelifar S.Madadi A.Entezari Z.Ghaffari Nejad M.Arbabi Z.Emkanjoo

Introduction
Catheter ablation (CA) of ventricular tachycardia (VT) has been shown to improve VT-free survival in patients with ICM. Complications and recurrence rates, after VT ablation in patients with ischemic cardiomyopathy (ICM) and non-ICM (NICM) are unknown.The goal of this study was to determine the outcomes of CA of VT in patients with ICMP compared with NICMP.

Methods
The study included 212 consecutive patients with ICMP (63.7%) and NICM (36.3%). Primary outcomes were early procedural success, VT recurrence and long-term mortality.

Results
The success rate of ablation was high in both groups, primary procedural success occurring more frequently in patients with NICMP (88.3% in NICMP vs. 79.3% in ICMP). Partial ablation success was achieved 15.6% in ICMP vs. 5.2% in NICMP patients (p=0.07). Unsuccessful ablation rates were similar in both groups. In median follow-up of 36 months, the cumulative recurrence of VT occurred in 48.1% of patients. VT recurrence occurred in 54.8% of ICMP vs 38.9% of NICMP (P = 0.026). The overall mortality rate was 22% in the ICMP vs 7% in the NICMP group (P = 0.007). cardiac mortality was significantly higher in the ICMP group than in the NICMP (19% vs. 6%) (P = 0.011). In the univariate model, several factors including age, LVEF, CKD, history of AF, NYHA functional class, VT cycle length, and partial ablation success were identified as predictors of VT recurrence during follow-up.

Conclusion
CA of VT was similarly effective in patients with NICM vs ICM, and high succsesful rate of VT control in long-term follow-up.
POSTER n° 05 : Association of anatomical and artificial intelligence guided substrate ablation in persistent atrial fibrillation
Ablation of atrial fibrillation Q.Voglimacci-Stephanopoli J.P.Albenque

Introduction
Radiofrequency ablation is a cornerstone therapy for atrial fibrillation. The purpose of this study is to evaluate the procedural outcomes of a new strategy combining anatomical and electrophysiological approach using artificial intelligence software in addition to standardized anatomical lesion set.

Methods
This is a prospective monocentric study including patients referred to symptomatic persistent AF ablation. At the beginning of the procedure, biatrial dispersion mapping was performed using artificial intelligence guided automated system (Vx1, Volta medical). Then, systematic linear anatomical lesion was performed including wide antral pulmonary vein isolation, ethanol infusion of Marshall Vein, roof/posterior wall line, mitral and cavotricuspid isthmus line followed by second biatrial dispersion mapping with ablation of dispersion areas. If conversion in atrial tachycardia or sinus rhythm failed, cardioversion was performed et lines were checked for bidirectional block.

Results
Fifteen patients were included between October 2023 and April 2024 with 87% of male and a mean age of 70±5 years. Mean LVEF was 52±10% and mean left atrium volume was 168±49 ml. Mean procedural time was 145±23 min with a mapping time of 39±12 min and ablation time of 30±5 min. 8 patients (53%) were converted to atrial tachycardia and/or sinus rhythm. Anatomical ablation was completed in all patients excepted for 2 patients missing cavotricuspid isthmus ablation. 13 patients (87%) had ethanol infusion of VOM. 2 patients had failure of block of the mitral isthmus line. Biatrial mapping with the Volta system showed a significant decrease in the dispersion areas after anatomical ablation (overall dispersion areas 108±57 vs 39±23, p<0,0001) even in non-ablated areas such as anterior wall (20±11 vs 13±10 ; p=0,007), left atrial bottom (16±11 vs 7±8 ; p=0,004) or interatrial septum (16±8 vs 8±6 ; p=0,002).

Conclusion
Association of anatomical and AI guided substrate ablation exhibits acute efficacy and may decrease the amount of ablation needed.
POSTER n° 10 : Initial Experience using the integrated GenesisRMN and NeuAngio 30F system
Ablation (other) O.Munciguerra S.Ambrosino A.Laezza L.Sena C.Pirozzi M.Volpicelli L.Caliendo

Introduction
The key points of Steretaxis are: precision, reach, effective catheter-tissue contact, safety of physician and patient. With this abstract we present our initial experience with Stereotaxis.

Methods
Our population includes 12 ablations (Table). All ablations were performed with GenesisRMN-NeuAngio 30 F (the only one currently present in the world), with the MagnoFlush G4 catheter, and they were preceded by Ensite X or RHYTHMIA HDx mapping. We have collected total mapping times, total radiofrequency times, total fluoroscopy times and fluoroscopy times during magnet activation in a database.

Results
From our initial experience we derived the first data. The procedures were all effective and passed without complications. We collected the procedure times, specifically the electroanatomic mapping times, the radiofrequency times, the total fluoro times and the fluoro times limited to the period of use of the magnets. The results are very encouraging, but the sample is small to draw general conclusions. We also collected interesting data on bipolar impedance drops that we are still analyzing to estimate an effective lesion index.

Conclusion
With our experience we are discovering the acute benefits of ablation procedures by exploiting the most cutting-edge technology currently in circulation. However, we need larger samples and more in-depth analysis to demonstrate the real advantage over pre-existing technology. For the moment, the integrated GenesisRMN and NeuAngio 30F system is proving to be the best technology for the health of our patients and our operators in our electrophysiology center. However, we need long-term data to confirm the acute data.
POSTER n° 20 : Impact of timing of early recurrences on health-care utilization during post-blanking period in patients after cryoballoon ablation – insights from the COMPARE-CRYO study using continuous rhythm monitoring
Ablation of atrial fibrillation S.Iqbal

Introduction
Early recurrences (ER) after pulmonary vein isolation (PVI) are common. It is unclear how timing of ERs impacts late recurrences (LR) and health care utilization. ERs are difficult to assess with non-invasive monitoring due to under sampling. We sought to evaluate the impact of timing of ERs using continuous rhythm monitoring on LRs and health care utilization.

Methods
This is a prespecified sub study of the COMPARE-CRYO study. The trial enrolled patients with paroxysmal atrial fibrillation and compared PVI with the PolarX and the ArcticFront cryoballoons. All patients underwent ICM implantation at the end of the PVI. ER was defined as recurrence of any atrial arrhythmia > 30 seconds between days 0-90 after PVI. LR was defined as recurrence of any atrial arrhythmia > 30 seconds between days 91-365.

Results
ER occurred in 117 of 201 patients (58%). 1 year freedom from recurrence was 81% without ER and 37% with ER (p<0.001). Patients with ERs up to the 3rd month of blanking period had frequent, longer episodes and total days spent in AF in both blanking and post-blanking period (Fig1, Table 1), persistence of episodes in the post-blanking period (Fig 2) and a higher number of redo procedures (Table 1). Significant correlations were observed between different parameters of AF assessment. (Table 2)

Conclusion
ER after cryoballoon PVI is common. ERs in the 3rd month of blanking period are associated to higher numbers of redo procedures, total number of episodes, duration of longest episodes and days spent in AF in the post-blanking period.
POSTER n° 22 : Vocal biomarkers as a novel diagnostic tool for identification of patients with atrial fibrillation
Ablation (other) T.Jadczyk B.Kamil P.Slawomir S.Krzysztof S.Grzegorz K.Milosz P.Maciej K.Monika K.Pawel W.Wojciech D.Hemmerling

Introduction
Introduction: Voice biomarkers are becoming a promising tool for the early detection and monitoring of cardiovascular diseases. Aim: To assess if acoustic characteristics extracted from human voice can differentiate patients with atrial fibrillation (AF) and individuals with sinus rhythm (SR).

Methods
The study enrolled 10 AF patients and 10 individuals in SR (all participants with co-existing heart failure). Propensity score matching was applied to reduce potential biases in baseline characteristics between groups. Human voice data, containing recordings of the vowel ""a"" with prolonged phonation, were parameterized using OpenSmile library in Python. The ComParE_2016 feature set and low-level descriptors were used to extract prosodic features (such as energy, pitch), spectral features (such as formants, MFCC-Mel-frequency cepstral coefficients), and voicing features (such as jitter, shimmer), among others. As a result, features were obtained along with their statistics: mean value, standard deviation, median, quartile 0.25, 0.5 and 0.75, giving a total of 390 features.

Results
Among all the parameters, only the JitterDDP (Difference of Difference of Periods) parameter was statistically significant. JitterDDP is particularly sensitive to small changes in the duration of phonation cycles. The mean, median, and quantile 50 (quantile50) values for jitterDDP can better reflect the overall instability of phonation in the AF patient population compared to those with SR. The results of the Mann-Whitney U test for jitterDDP_sma_mean (U-statistic = 78.0, p-value = 0.033398), jitterDDP_sma_median (U-statistic = 77.0, p-value = 0.040239), and jitterDDP_sma_quantile50 (U-statistic = 77.0, p-value = 0.040239) indicate statistically significant differences between the groups.

Conclusion
Human voice biomarkers can be used to identify AF patients. Jitter measures the instability of the frequency of phonation. Increased heart rhythm instability in AF patients can cause more pronounced changes in the frequency of vocal fold vibrations, leading to higher jitter values. Future research is required to evaluate results of this hypothesis-generating experiment
POSTER n° 23 : Incidence, spatial distribution and boundary characteristics during left atrial macro-reentrant atrial tachycardia
Ablation (other) M.De Smet R.Van Den Abeele M.El Haddad B.De Becker C.François J.B.Le Polain De Waroux R.Tavernier S.Knecht S.Hendrickx N.Vandersickel M.Duytschaever

Introduction
Macro-reentrant atrial tachycardia (MRAT) rotates around two critical boundaries (CBs). The presence of 2 boundaries (2B) only, follows a single loop activation pattern. An additional non-critical boundary (NCB), results in two loops with a common isthmus. Here, we determined the spatial distribution of boundaries and their impact on entrainment and ablation response.

Methods
We reviewed 106 LA-MRAT cases where high-definition mapping was combined with entrainment.

Results
Prior ablation or cardiac surgery, age, LA volume, AT cycle length, mapping points and PPI manoeuvres were 89.3%, 4.6%, 70±8years, 173±43mL, 280±57ms, 5209±4913 and 6±5. Potential boundaries were the mitral valve (MV), right and left pulmonary veins (RPV,LPV) or an isolated scar or line of block. LA-MRAT predominantly occurred in 2B (n=43) and 3B topology (n=54). In 9 cases, isolated scar formed 4 boundaries. 2B topology occurred with roof line block (joining RPV and LPV as boundary,n=37) or posterior MI line (joining MV and LPV,n=5). 3B phenotypes showed two loops around MV and LPV(n=25), MV and RPV(n=14) or LPV and RPV(n=9). In 2B cases, joining CBs by ablation invariably terminated the arrhythmia. In 16 cases involving 3 or 4 boundaries, entrainment suggested an active and passive loop (around CB1 and CB2). Ablation from CB1 to NCB shifted activation to a slower AT. Ablation, connecting the new CB to CB2, terminated the second AT.

Conclusion
Patients with LA-MRAT after prior ablation, show two activation loops that are ablated at the common isthmus. Mitral or roof block combined with absence of isolated scar may rule out a second loop.

Wednesday / Mercredi

16

Thursday / Jeudi

17

Friday / Vendredi

18

Session 1 | 2024 AF ablation guidelines: what is new? And what remains to be determined

Session 2 | AF and brain

Session 3 | AF ablation

Session 4 | Persistent AF Ablation

Session 5 | Everything you need to know about PFA

Session 6 | Linear lesions for AF/AT

Session 7 | Sustainability in cardiac electrophysiology

Session 8 | Treatment of cardiac arrhythmias in specific conditions

Session 9 | Sudden cardiac death prediction

Session 10 | VT/VF/SCD/Syncope: Autonomic nervous system

Session 11 | Arrhythmia in Congenital Heart Disease

Session 12 | Unusual treatment for VT

Session 13 | Assessing the substrate of ventricular arrhythmia

Session 14 | What is beyond bipolar depolarization mapping for ventricular arrhythmias

Session 15 | Stereotactic Arrhythmia Radioablation of Ventricular Tachycardia

Session 16 | Tools to identify and treat difficult PVCs

Session 17 | Ventricular fibrillation

Session 1 |Les explorations électrophysiologiques endocavitaires

Session 2 | Les ablations de tachycardies supraventriculaires

Session 3 | Troubles du rythme ventriculaire

Session 4 | Se repérer / se guider : travail en collaboration IDE / ingénieur d’application

Session 5 | Les différentes énergies : travail en collaboration IDE / médecin

Session 6 | Pédiatrie, cardiopathie congénitale et canalopathie

Session 7 | Ambulatoire

Session 8 | La FA

Session 09 | Gestion des complications

Session 10 |Gestion du stress et de la douleur

Session 11 | Et vos centres ? : présentez-vous ? Votre spécificité ? Écoresponsable ?

Session 12 | Évolutions professionnelles

Interpretation of on-board electrograms

Interpretation of surface ECG traces, fine QRS

EP study: interpretation of endocavitary tracings

Interpretation of 3D maps

Interpretation of 3D maps

Interpretation of on-board electrograms

With the support of Abbott

With the support of Biosense Webster

With the support of Boston Scientific

With the support of Medtronic

With the support of Zoll Medical

AKSU Tolga

ALBA Céline

ALBENQUE Jean Paul

ALIOT Etienne

AMRAOUI Sana

ANSELME Frederic

ANTER Elad

ARENTZ Thomas

ARTIGUES Laurence

BASU Shubhayu

BATTAGLIA Alberto

BEHAGHEL Albin

BENALI Karim

BERNUS Olivier

BOGUN Frank

BOIRE Nelly

BOURRAT Cédric

BOVEDA Serge

BRIDET Julie

BROOK Clare

BRUN Caroline

BUCKLEY Una

BUN Sok-Sithikun

CARRABELLI Adrien

CHAMP RIGOT Laure

CHEVALIER Philippe

CLEMENTY Nicolas

CLEQUIN Etienne

COCHET Hubert

COMBES Stéphane

COMBES Nicolas

CORONEL Ruben

CUSSONNEAU Maryse

DA COSTA Antoine